Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Alternet Systems (ALYI): Predictive Analytics Market Expected to Grow to $9.2 Billion by 2020

From drug discovery to price optimization, across virtually every industry, more companies are using predictive analytics to increase revenue, reduce costs, and modernize the way they do business. Alternet Systems, Inc. (OTCQB: ALYI) revolutionizes how leading organizations optimize data analytics and automate marketing research operations. The company’s integrated analytics, micro segmentation and marketing automation technologies […]

Agora Holdings, Inc. (AGHI) Continues Steadfast Integration with YouTube

A leading international family entertainment and media enterprise, Agora Holdings, Inc. (OTC: AGHI) offers TV, studio entertainment, interactive media, media networks, and consumer products. Through its wholly-owned subsidiary, Geegle Media, the company aims to fill the needs of social media, TV, data storage software, and other optimizing solutions. In July 2015, Agora Holdings, through Geegle […]

Immune Therapeutics’ (IMUN) Lodonal Armors Africa against AIDS

Thought to have originated in Africa, the acquired immunodeficiency syndrome (AIDS) has undoubtedly become a scourge of the continent, particularly south of the Sahara. According to AVERT, the U.K.-based international charity, in sub-Saharan Africa, 24.7 million people, or about 4.7% of the continental population, were living with the human immunodeficiency virus (HIV) in 2013, the […]

Nutra Pharma Corporation (NPHC) Proves Strength in Numbers Can Make a Difference

A biotechnology company, Nutra Pharma Corporation (OTCQB: NPHC) focuses on acquiring, licensing, and commercializing pharmaceutical products and technologies. The company concentrates on preventing and treating neurological disorders, cancer, and autoimmune and infectious diseases. Currently, Nutra Pharma offers Nyloxin® and Nyloxin® Extra Strength, the only non-narcotic and non-addictive treatments for severe pain that are sold over-the-counter. […]

Halitron, Inc. (HAON) Constructing Growth through Acquisitions and Roll-Up Know-How

Halitron, Inc. (OTC: HAON) is an equity holding company that focuses on acquiring sales, marketing, and manufacturing businesses and weaving their assets into its existing infrastructure. The company acquires bankrupt, distressed and insolvent companies inexpensively. HAON also acquires profitable companies at a multiple of earnings ranging from two to four times, before the deduction of […]

 

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.